Dolby Laboratories (DLB) Cash from Restructuring (2019 - 2020)
Quarterly Cash from Restructuring rose 1571.81% to $8.1 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $9.3 million through Dec 2020, down 72.5% year-over-year, with the annual reading at $1.6 million for FY2020, 95.07% down from the prior year.
Dolby Laboratories filings provide 2 years of Cash from Restructuring readings, the most recent being $8.1 million for Q4 2020.
- Cash from Restructuring hit $8.1 million in Q4 2020 for Dolby Laboratories, up from $199000.0 in the prior quarter.
- Across five years, Cash from Restructuring topped out at $27.5 million in Q2 2019 and bottomed at $116000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 25, 2020 | 8.13 Mn |
| Sep 25, 2020 | 199,000.00 |
| Jun 26, 2020 | 839,000.00 |
| Mar 27, 2020 | 116,000.00 |
| Dec 27, 2019 | 486,000.00 |
| Sep 27, 2019 | 5.79 Mn |
| Jun 28, 2019 | 27.46 Mn |